Animal-free tumor necrosis factors (TNFs), particularly recombinant TNF-α, represent ethically produced cytokines manufactured without animal-derived components, eliminating contamination risks while maintaining potent pro-inflammatory, cytotoxic, and immunomodulatory activities.

These GMP-grade proteins support advanced cell therapy manufacturing, tumor microenvironment studies, and drug screening with enhanced safety for clinical translation.

Production Without Animal Components

Traditional TNF-α production often involves mammalian cell cultures supplemented with fetal bovine serum, introducing potential TSE/BSE prions, viral pathogens, and lot-to-lot variability. Animal-free TNFs employ:

• E. coli expression: Production in dedicated animal-free facilities using chemically defined media.
• Non-animal purification: Hydrophobic interaction chromatography (HIC), ion exchange chromatography (IEX), and size exclusion chromatography (SEC) using synthetic resins.
• Animal-free lyophilization: Use of human serum albumin alternatives or carrier-free formulations.
• Endotoxin control: Stringent purification achieving levels <0.1 EU/µg through validated filtration processes.

Resulting proteins achieve >97% purity by SDS-PAGE and exhibit biological potency consistent with pharmacopeial standards.